Marie-Annick Le Pogam

Dr. Marie-Annick Le Pogam

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2018 in Research Synthesis Methods
Verified
Journal Article
Open access
PDF file
PPPiotr Przybyła
Piotr Przybyła
ABAustin J. Brockmeier
Austin J. Brockmeier
GKGeorgios Kontonatsios
Georgios Kontonatsios
MPMarie-Annick Le Pogam
Marie-Annick Le Pogam
JMJohn McNaught
John McNaught
SASophia Ananiadou
Sophia Ananiadou
Screening references is a time‐consuming step necessary for systematic reviews and guideline development. Previous studies have shown that human effort can be reduced by using machine learning software to prioritise large reference collections such that most of the relevant references are identified before screening is completed. We describe and evaluate RobotAnalyst, a Web‐based software system that combines text‐mining and machine learning algorithms for organising references by their content and actively prioritising them based on a relevancy classification model trained and updated throughout the process. We report an evaluation over 22 reference collections (most are related to public health topics) screened using RobotAnalyst with a total of 43 610 abstract‐level decisions. The number of references that needed to be screened to identify 95% of the abstract‐level inclusions for the evidence review was reduced on 19 of the 22 collections. Significant gains over random sampling were achieved for all reviews conducted with active prioritisation, as compared with only two of five when prioritisation was not used. RobotAnalyst's descriptive clustering and topic modelling functionalities were also evaluated by public health analysts. Descriptive clustering provided more coherent organisation than topic modelling, and the content of the clusters was apparent to the users across a varying number of clusters. This is the first large‐scale study using technology‐assisted screening to perform new reviews, and the positive results provide empirical evidence that RobotAnalyst can accelerate the identification of relevant studies. The results also highlight the issue of user complacency and the need for a stopping criterion to realise the work savings.

6 January 2020 in BMJ Open
Verified
Journal Article
Open access
PDF file
LXLuta Xhyljeta
Luta Xhyljeta
CBChristophe Bagnoud
Christophe Bagnoud
MLMark Lambiris
Mark Lambiris
ADAnne Decollogny
Anne Decollogny
YEYves Eggli
Yves Eggli
JMJoachim Marti
Joachim Marti
Objective This study aimed to examine the prevalence and determinants of benzodiazepine prescription among older adults in Switzerland, and analyse association with hospitalisation and costs. Design Retrospective analysis of claims data. Setting The study was conducted in nine cantons in Switzerland. Participants Older adults aged 65 years and older enrolled with a large Swiss health insurance company participated in the study. Primary and secondary outcome measures The primary outcome was prevalence of benzodiazepine prescription. The secondary outcomes were (1) determinants of any benzodiazepine prescription; (2) the association between any prescription and the probability of hospitalisation for trauma and (3) the association between any prescription and total healthcare expenditures. Results Overall, 69 005 individuals were included in the study. Approximately 20% of participants had at least one benzodiazepine prescription in 2017. Prescription prevalence increased with age (65–69: 15.9%; 70–74: 18.4%; 75–80: 22.5%; >80: 25.8%) and was higher in women (25.1%) compared with men (14.6%). Enrollees with the highest deductible of Swiss Francs (CHF) 2500 were 70% less likely to receive a prescription than enrollees with the lowest deductible of CHF 300 (adjusted OR=0.29, 95% CI 0.24 to 0.35). Individuals with at least one prescription had a higher probability of hospitalisation for trauma (OR=1.31, 95% CI 1. 20 to 1.1.44), and 70% higher health care expenditures (β=0.72, 95% CI 0. 67 to 0.77). Enrollees in canton Valais were three times more likely to receive a prescription compared to enrollees from canton Aargau (OR=2.84, 95% 2.51 to 3.21). Conclusions The proportion of older adults with at least one benzodiazepine prescription is high, as found in the data of one large Swiss health insurance company. These enrollees are more likely to be hospitalised for trauma and have higher healthcare expenditures. Important differences in prescription prevalence across cantons were observed, suggesting potential overuse. Further research is needed to understand the drivers of variation, prescription patterns across providers, and trends over time.

10 January 2022 in eClinicalMedicine
Verified
Journal Article
Open access
MPMarie-Annick Le Pogam
Marie-Annick Le Pogam
LSLaurence Seematter-Bagnoud
Laurence Seematter-Bagnoud
TNTapio Niemi
Tapio Niemi
DADan Assouline
Dan Assouline
NGNathan Gross
Nathan Gross
BSBrigitte Santos-Eggimann
Brigitte Santos-Eggimann
Most claims-based frailty instruments have been designed for group stratification of older populations according to the risk of adverse health outcomes and not frailty itself. We aimed to develop and validate a tool based on one-year hospital discharge data for stratification on Fried's frailty phenotype (FP). We used a three-stage development/validation approach. First, we created a clinical knowledge-driven electronic frailty score (eFS) calculated as the number of deficient organs/systems among 18 critical ones identified from the International Statistical Classification of Diseases and Related Problems, 10th Revision (ICD-10) diagnoses coded in the year before FP assessment. Second, for eFS development and internal validation, we linked individual records from the Lc65+ cohort database to inpatient discharge data from Lausanne University Hospital (CHUV) for the period 2004-2015. The development/internal validation sample included community-dwelling, non-institutionalised residents of Lausanne (Switzerland) recruited in the Lc65+ cohort in three waves (2004, 2009, and 2014), aged 65-70 years at enrolment, and hospitalised at the CHUV at least once in the year preceding the FP assessment. Using this sample, we selected the best performing model for predicting the dichotomised FP, with the eFS or ICD-10-based variables as predictors. Third, we conducted an external validation using 2016 Swiss nationwide hospital discharge data and compared the performance of the eFS model in predicting 13 adverse outcomes to three models relying on well-designed and validated claims-based scores (Claims-based Frailty Index, Hospital Frailty Risk Score, Dr Foster Global Frailty Score). In the development/internal validation sample (n = 469), 14·3% of participants (n = 67) were frail. Among 34 models tested, the best-subsets logistic regression model with four predictors (age and sex at FP assessment, time since last hospital discharge, eFS) performed best in predicting the dichotomised FP (area under the curve=0·71; F1 score=0·39) and one-year adverse health outcomes. On the external validation sample (n = 54,815; 153 acute care hospitals), the eFS model demonstrated a similar performance to the three other claims-based scoring models. According to the eFS model, the external validation sample showed an estimated prevalence of 56·8% (n = 31,135) of frail older inpatients at admission. The eFS model is an inexpensive, transportable and valid tool allowing reliable group stratification and individual prioritisation for comprehensive frailty assessment and may be applied to both hospitalised and community-dwelling older adults. The study received no external funding.

13 November 2020 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JRJean Regina
Jean Regina
Matthaios Papadimitriou-OlivgerisMatthaios Papadimitriou-Olivgeris
Matthaios Papadimitriou-Olivgeris
RBRaphaël Burger
Raphaël Burger
MPMarie-Annick Le Pogam
Marie-Annick Le Pogam
TNTapio Niemi
Tapio Niemi
LLLoïc Lhopitallier
Loïc Lhopitallier
Background: This study aims to describe the epidemiology of COVID-19 patients in a Swiss university hospital. Methods: This retrospective observational study included all adult patients hospitalized with a laboratory confirmed SARS-CoV-2 infection from March 1 to March 25, 2020. We extracted data from electronic health records. The primary outcome was the need to mechanical ventilation at day 14. We used multivariate logistic regression to identify risk factors for mechanical ventilation. Follow-up was of at least 14 days. Results: 145 patients were included in the multivariate model, of whom 36 (24.8%) needed mechanical ventilation at 14 days. The median time from symptoms onset to mechanical ventilation was 9·5 days (IQR 7.00, 12.75). Multivariable regression showed increased odds of mechanical ventilation with age (OR 1.09 per year, 95% CI 1.03–1.16, p = 0.002), in males (OR 6.99, 95% CI 1.68–29.03, p = 0.007), in patients who presented with a qSOFA score ≥2 (OR 7.24, 95% CI 1.64–32.03, p = 0.009), with bilateral infiltrate (OR 18.92, 3.94–98.23, p<0.001) or with a CRP of 40 mg/l or greater (OR 5.44, 1.18–25.25; p = 0.030) on admission. Patients with more than seven days of symptoms on admission had decreased odds of mechanical ventilation (0.087, 95% CI 0.02–0.38, p = 0.001). Conclusions: This study gives some insight in the epidemiology and clinical course of patients admitted in a European tertiary hospital with SARS-CoV-2 infection. Age, male sex, high qSOFA score, CRP of 40 mg/l or greater and a bilateral radiological infiltrate could help clinicians identify patients at high risk for mechanical ventilation.

1 December 2014 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
PPPerrine Parize
Perrine Parize
SBSandrine Billaud
Sandrine Billaud
ABAnne L. Bienvenu
Anne L. Bienvenu
SBStéphanie Bourdy
Stéphanie Bourdy
MPMarie-Annick Le Pogam
Marie-Annick Le Pogam
IDIsabelle Durieu
Isabelle Durieu

5 September 2019 in BMJ Open
Verified
Journal Article
Open access
PDF file
STSandrine Touzet
Sandrine Touzet
POPauline Occelli
Pauline Occelli
ADAngelique Denis
Angelique Denis
PCPierre-Loïc Cornut
Pierre-Loïc Cornut
JFJean-Baptiste Fassier
Jean-Baptiste Fassier
CBCarole Burillon
Carole Burillon
Objective and setting Primary prevention, comprising patient-oriented and environmental interventions, is considered to be one of the best ways to reduce violence in the emergency department (ED). We assessed the impact of a comprehensive prevention programme aimed at preventing incivility and verbal violence against healthcare professionals working in the ophthalmology ED (OED) of a university hospital. Intervention The programme was designed to address long waiting times and lack of information. It combined a computerised triage algorithm linked to a waiting room patient call system, signage to assist patients to navigate in the OED, educational messages broadcast in the waiting room, presence of a mediator and video surveillance. Participants All patients admitted to the OED and those accompanying them. Design Single-centre prospective interrupted time-series study conducted over 18 months. Primary outcome Violent acts self-reported by healthcare workers committed by patients or those accompanying them against healthcare workers. Secondary outcomes Waiting time and length of stay. Results There were a total of 22 107 admissions, including 272 (1.4%) with at least one act of violence reported by the healthcare workers. Almost all acts of violence were incivility or verbal harassment. The rate of violence significantly decreased from the pre-intervention to the intervention period (24.8, 95% CI 20.0 to 29.5, to 9.5, 95% CI 8.0 to 10.9, acts per 1000 admissions, p<0.001). An immediate 53% decrease in the violence rate (incidence rate ratio=0.47, 95% CI 0.27 to 0.82, p=0.0121) was observed in the first month of the intervention period, after implementation of the triage algorithm. Conclusion A comprehensive prevention programme targeting patients and environment can reduce self-reported incivility and verbal violence against healthcare workers in an OED. Trial registration number NCT02015884